News

Kim Keister leads the News & Politics team of AARP Media and is the editor / manager of the AARP Blog. He's been a journalist for decades, including eight years at AARP Bulletin and AARP.org. Follow him on Twitter @kimkeister

La Corte Suprema da su fallo a favor de la legalidad de los subsidios de salud en todos los estados

Cerca de 6.4 millones de personas que compran seguros de salud a través del programa de intercambio federal de los estados podrán continuar recibiendo estos subsidios, luego de que la Corte Suprema de Estados Unidos diera su fallo el 25 de junio a favor de que la ACA (Ley del Cuidado de la Salud a Bajo Precio) permita apoyos financieros como esos. Los defensores de la ley aplaudieron la decisión de la Corte (en inglés). “Las metas de la Ley …

Supreme Court Rules Health Insurance Subsidies Can Continue in All States

Some 6.4 million Americans in states relying on the healthcare.gov federal insurance exchange will continue to receive subsidies for coverage after the U.S. Supreme Court ruled June 25 that the Affordable Care Act allows such financial support. The law’s supporters applauded the court’s decision. “The ACA’s goals of improving affordability and removing barriers to access for health insurance have been critical in reducing the number of uninsured Americans,” said Jo Ann Jenkins, CEO of AARP. “Importantly, for older Americans, we …

How to Talk About Death … and Life

Many Americans, it seems, have a hard time talking about death. Even doctors struggle to deal with the mortality of patients who they know aren’t going to make it. That’s the focus of Being Mortal: Conversations of Death and Dying, Atul Gawande’s adaptation of his bestselling book to a Frontline segment that begins airing Feb. 10 on PBS platforms. A surgeon and writer, Gawande chalks up doctors’ fears to their sense of professional competence. In gaining experience, “Among the most …

Supreme Court: Drugmakers’ Pay-for-Delay Deals Can Be Illegal

Deals between brand-name drugmakers and their generic drug competitors that keep cheaper products off the market might illegally prevent competition, the U.S. Supreme Court ruled June 17. In so-called pay-for-delay deals or reverse settlements, a patent holder pays a would-be competitor not to sell a generic version of a drug for a specified period of time. The brand-name manufacturer can continue to charge monopoly prices, and the generic company is compensated for inaction. In Federal Trade Commission v. Actavis, the …

Does a Top Drugmaker’s Playbook Stifle Competition?

If you owned the bestselling prescription drug of all time and its patent was about to expire, how would you prepare for competition from generic drugs? You might look at what Pfizer did when time was running out on its patent for the cholesterol-lowering drug Lipitor, which by 2011 had become the all-time bestselling prescription drug of any kind. And you could save yourself some time by reviewing a new AARP Public Policy Institute case study of Pfizer’s approach. The …

Will the Obamas All Get Tattoos?

On the April 24 “Today” show, President Obama laid out the strategy he and Michelle have devised to discourage their daughters from getting tattoos. “What we’ve said to the girls is, ‘If you guys ever decided you’re going to get a tattoo, then mommy and me will get the exact same tattoo in the same place. And we’ll go on YouTube and show it off as a family tattoo,” Obama told Savannah Guthrie in a taped interview. “And our thinking …